TY - JOUR AU - Attems, J. PY - 2005 DA - 2005// TI - Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms JO - Acta Neuropathol VL - 110 UR - https://doi.org/10.1007/s00401-005-1074-9 DO - 10.1007/s00401-005-1074-9 ID - Attems2005 ER - TY - JOUR AU - Attems, J. AU - Jellinger, K. A. AU - Lintner, F. PY - 2005 DA - 2005// TI - Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy JO - Acta Neuropathol VL - 110 UR - https://doi.org/10.1007/s00401-005-1064-y DO - 10.1007/s00401-005-1064-y ID - Attems2005 ER - TY - JOUR AU - Bales, K. R. PY - 2016 DA - 2016// TI - Passive immunotherapy targeting amyloid-beta reduces cerebral amyloid angiopathy and improves vascular reactivity JO - Brain VL - 139 UR - https://doi.org/10.1093/brain/awv313 DO - 10.1093/brain/awv313 ID - Bales2016 ER - TY - JOUR AU - Bayer, A. J. PY - 2005 DA - 2005// TI - Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD JO - Neurology VL - 64 UR - https://doi.org/10.1212/01.WNL.0000148604.77591.67 DO - 10.1212/01.WNL.0000148604.77591.67 ID - Bayer2005 ER - TY - JOUR AU - Boche, D. PY - 2008 DA - 2008// TI - Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain JO - Brain VL - 131 UR - https://doi.org/10.1093/brain/awn261 DO - 10.1093/brain/awn261 ID - Boche2008 ER - TY - JOUR AU - Boche, D. PY - 2010 DA - 2010// TI - Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis JO - Acta Neuropathol VL - 120 UR - https://doi.org/10.1007/s00401-010-0719-5 DO - 10.1007/s00401-010-0719-5 ID - Boche2010 ER - TY - JOUR AU - Bolduc, D. M. PY - 2016 DA - 2016// TI - The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase JO - eLife VL - 5 UR - https://doi.org/10.7554/eLife.17578 DO - 10.7554/eLife.17578 ID - Bolduc2016 ER - TY - JOUR AU - Burnouf, S. PY - 2015 DA - 2015// TI - Abeta43 is neurotoxic and primes aggregation of Abeta40 in vivo JO - Acta Neuropathol VL - 130 UR - https://doi.org/10.1007/s00401-015-1419-y DO - 10.1007/s00401-015-1419-y ID - Burnouf2015 ER - TY - JOUR AU - Gravina, S. A. PY - 1995 DA - 1995// TI - Amyloid beta protein (a beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at a beta 40 or a beta 42(43) JO - J Biol Chem VL - 270 UR - https://doi.org/10.1074/jbc.270.13.7013 DO - 10.1074/jbc.270.13.7013 ID - Gravina1995 ER - TY - JOUR AU - Hawkes, C. A. PY - 2014 DA - 2014// TI - Failure of perivascular drainage of beta-amyloid in cerebral amyloid angiopathy JO - Brain Pathol VL - 24 UR - https://doi.org/10.1111/bpa.12159 DO - 10.1111/bpa.12159 ID - Hawkes2014 ER - TY - JOUR AU - Herzig, M. C. PY - 2004 DA - 2004// TI - Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis JO - Nat Neurosci VL - 7 UR - https://doi.org/10.1038/nn1302 DO - 10.1038/nn1302 ID - Herzig2004 ER - TY - JOUR AU - Holmes, C. PY - 2008 DA - 2008// TI - Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61075-2 DO - 10.1016/S0140-6736(08)61075-2 ID - Holmes2008 ER - TY - JOUR AU - Iizuka, T. PY - 1995 DA - 1995// TI - Amyloid beta-protein ending at Thr43 is a minor component of some diffuse plaques in the Alzheimer's disease brain, but is not found in cerebrovascular amyloid JO - Brain Res VL - 702 UR - https://doi.org/10.1016/0006-8993(95)01163-2 DO - 10.1016/0006-8993(95)01163-2 ID - Iizuka1995 ER - TY - JOUR AU - Iwatsubo, T. PY - 1994 DA - 1994// TI - Visualization of a beta 42(43) and a beta 40 in senile plaques with end-specific a beta monoclonals: evidence that an initially deposited species is a beta 42(43) JO - Neuron VL - 13 UR - https://doi.org/10.1016/0896-6273(94)90458-8 DO - 10.1016/0896-6273(94)90458-8 ID - Iwatsubo1994 ER - TY - JOUR AU - Jarrett, J. T. AU - Berger, E. P. AU - Lansbury, P. T. PY - 1993 DA - 1993// TI - The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease JO - Biochemistry VL - 32 UR - https://doi.org/10.1021/bi00069a001 DO - 10.1021/bi00069a001 ID - Jarrett1993 ER - TY - JOUR AU - Johnson-Wood, K. PY - 1997 DA - 1997// TI - Amyloid precursor protein processing and a beta42 deposition in a transgenic mouse model of Alzheimer disease JO - Proc Natl Acad Sci U S A VL - 94 UR - https://doi.org/10.1073/pnas.94.4.1550 DO - 10.1073/pnas.94.4.1550 ID - Johnson-Wood1997 ER - TY - JOUR AU - Karran, E. AU - Mercken, M. AU - Strooper, B. PY - 2011 DA - 2011// TI - The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics JO - Nat Rev Drug Discov VL - 10 UR - https://doi.org/10.1038/nrd3505 DO - 10.1038/nrd3505 ID - Karran2011 ER - TY - JOUR AU - Kumar-Singh, S. PY - 2002 DA - 2002// TI - In vitro studies of Flemish, Dutch, and wild-type β-amyloid provide evidence for two-staged neurotoxicity JO - Neurobiol Dis VL - 11 UR - https://doi.org/10.1006/nbdi.2002.0529 DO - 10.1006/nbdi.2002.0529 ID - Kumar-Singh2002 ER - TY - JOUR AU - Lee, M. PY - 2005 DA - 2005// TI - Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies JO - Ann Neurol VL - 58 UR - https://doi.org/10.1002/ana.20592 DO - 10.1002/ana.20592 ID - Lee2005 ER - TY - BOOK AU - Nicoll, J. PY - 2019 DA - 2019// TI - Persistent neuropathological effects 14 years following amyloid-β immunisation in Alzheimer’s disease ID - Nicoll2019 ER - TY - JOUR AU - Nicoll, J. A. PY - 2003 DA - 2003// TI - Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm840 DO - 10.1038/nm840 ID - Nicoll2003 ER - TY - JOUR AU - Nicoll, J. A. PY - 2004 DA - 2004// TI - Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement JO - Neurobiol Aging VL - 25 UR - https://doi.org/10.1016/j.neurobiolaging.2004.02.003 DO - 10.1016/j.neurobiolaging.2004.02.003 ID - Nicoll2004 ER - TY - JOUR AU - Nicoll, J. A. PY - 2006 DA - 2006// TI - Abeta species removal after abeta42 immunization JO - J Neuropathol Exp Neurol VL - 65 UR - https://doi.org/10.1097/01.jnen.0000240466.10758.ce DO - 10.1097/01.jnen.0000240466.10758.ce ID - Nicoll2006 ER - TY - JOUR AU - Patton, R. L. PY - 2006 DA - 2006// TI - Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis JO - Am J Pathol VL - 169 UR - https://doi.org/10.2353/ajpath.2006.060269 DO - 10.2353/ajpath.2006.060269 ID - Patton2006 ER - TY - JOUR AU - Prada, C. M. PY - 2007 DA - 2007// TI - Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging JO - J Neurosci VL - 27 UR - https://doi.org/10.1523/JNEUROSCI.5426-06.2007 DO - 10.1523/JNEUROSCI.5426-06.2007 ID - Prada2007 ER - TY - JOUR AU - Qi-Takahara, Y. PY - 2005 DA - 2005// TI - Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase JO - J Neurosci VL - 25 UR - https://doi.org/10.1523/JNEUROSCI.1575-04.2005 DO - 10.1523/JNEUROSCI.1575-04.2005 ID - Qi-Takahara2005 ER - TY - JOUR AU - Revesz, T. PY - 2003 DA - 2003// TI - Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view JO - J Neuropathol Exp Neurol VL - 62 UR - https://doi.org/10.1093/jnen/62.9.885 DO - 10.1093/jnen/62.9.885 ID - Revesz2003 ER - TY - JOUR AU - Roher, A. E. PY - 1993 DA - 1993// TI - Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease JO - J Biol Chem VL - 268 ID - Roher1993 ER - TY - JOUR AU - Saito, T. PY - 2011 DA - 2011// TI - Potent amyloidogenicity and pathogenicity of Abeta43 JO - Nat Neurosci VL - 14 UR - https://doi.org/10.1038/nn.2858 DO - 10.1038/nn.2858 ID - Saito2011 ER - TY - JOUR AU - Sakai, K. PY - 2014 DA - 2014// TI - Abeta immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy JO - Acta Neuropathol VL - 128 UR - https://doi.org/10.1007/s00401-014-1340-9 DO - 10.1007/s00401-014-1340-9 ID - Sakai2014 ER - TY - JOUR AU - Schilling, S. PY - 2018 DA - 2018// TI - Passive Abeta Immunotherapy: Current Achievements and Future Perspectives JO - Molecules VL - 23 UR - https://doi.org/10.3390/molecules23051068 DO - 10.3390/molecules23051068 ID - Schilling2018 ER - TY - JOUR AU - Takami, M. PY - 2009 DA - 2009// TI - Gamma-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment JO - J Neurosci VL - 29 UR - https://doi.org/10.1523/JNEUROSCI.2362-09.2009 DO - 10.1523/JNEUROSCI.2362-09.2009 ID - Takami2009 ER - TY - JOUR AU - Tarasoff-Conway, J. M. PY - 2015 DA - 2015// TI - Clearance systems in the brain-implications for Alzheimer disease JO - Nat Rev Neurol VL - 11 UR - https://doi.org/10.1038/nrneurol.2015.119 DO - 10.1038/nrneurol.2015.119 ID - Tarasoff-Conway2015 ER - TY - JOUR AU - Thal, D. R. PY - 2002 DA - 2002// TI - Two types of sporadic cerebral amyloid angiopathy JO - J Neuropathol Exp Neurol VL - 61 UR - https://doi.org/10.1093/jnen/61.3.282 DO - 10.1093/jnen/61.3.282 ID - Thal2002 ER - TY - JOUR AU - Wang, Y. PY - 2017 DA - 2017// TI - Lessons from anti-amyloid-beta immunotherapies in Alzheimer disease: aiming at a moving target JO - Neurodegener Dis VL - 17 UR - https://doi.org/10.1159/000478741 DO - 10.1159/000478741 ID - Wang2017 ER - TY - JOUR AU - Welander, H. PY - 2009 DA - 2009// TI - Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains JO - J Neurochem VL - 110 UR - https://doi.org/10.1111/j.1471-4159.2009.06170.x DO - 10.1111/j.1471-4159.2009.06170.x ID - Welander2009 ER - TY - JOUR AU - Zotova, E. PY - 2013 DA - 2013// TI - Inflammatory components in human Alzheimer's disease and after active amyloid-beta42 immunization JO - Brain VL - 136 UR - https://doi.org/10.1093/brain/awt210 DO - 10.1093/brain/awt210 ID - Zotova2013 ER -